Valeant CEO says no need to adjust offer for Allergan

June 17 Tue Jun 17, 2014 9:29am EDT

June 17 (Reuters) - Valeant Pharmaceuticals Inc Chief Executive Officer Mike Pearson said on Tuesday that he sees no need to adjust the company's offer for Allergan Inc .

Valeant's bid includes both stock and cash, but its shares have fallen for 10 straight sessions. (Reporting by Rod Nickel in Winnipeg, Manitoba)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.